Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study)
Opioid-induced constipation (OIC) is a common symptom in cancer patients treated with opioids with a prevalence of up to 59%. International guidelines recommend standard laxatives such as macrogol/electrolytes...
Source: BMC Palliative Care - Category: Palliative Care Authors: K.R.J. Kistemaker, A. de Graeff, M. Crul, G. de Klerk, P.M. van de Ven, M.P. van der Meulen, L. van Zuylen and M.A.H. Steegers Tags: Study Protocol Source Type: research
More News: Cancer | Cancer & Oncology | Constipation | Magnesium | Palliative | Palliative Care | Study